Search research articles
Contact Us
Filters
Showing results (131-140 of 167) with videos related to
Page
of 17
Sort By:
Leukemia & Lymphoma
|
November 21, 2023
Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I-II follicular lymphoma from the SEER database (2000-2015)
Qiuzi Zhong, Ye Liu, Yunpeng Wu, et al.
BMC Cancer
|
January 17, 2020
Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
Mingqiu Chen, Xiaohong Liu, Chun Han, et al.
Oncotarget
|
April 30, 2016
Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
Jiang Chen, Tong Ji, Jie Zhao, et al.
BMC Cancer
|
January 8, 2025
Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03 A)
Yuanji Xu, Chuyan Lin, Chun Han, et al.
Scientific Reports
|
July 21, 2025
Accuracy and acceptability of self-sampling HPV testing in cervical cancer screening: a population-based study in rural Yunnan, China
Rufei Duan, Hongying Yang, Xiuwei Zhai, et al.
Elife
|
October 21, 2024
Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunities
Honglei Zhang, Chao Liu, Shuting Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
February 18, 2025
[Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022]
Ruke Tang, Yujie Lei, Lianhua Ye, et al.
The Lancet. Oncology
|
January 15, 2026
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
Liang Zhang, Xiqin Zhang, Lin Wu, et al.
Nature Communications
|
May 25, 2026
Directing intermediate phase crystallographic orientation promotes carbon-based CsPbI<sub>3</sub> perovskite solar cells to beyond 20% efficiency
Gaofeng Li, Jieke Tan, Changqing Lin, et al.
JTO Clinical and Research Reports
|
February 19, 2024
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis
Jie Wang, Yi-Long Wu, Shun Lu, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 167) with videos related to
Sort By:
Page
of 17
Leukemia & Lymphoma
|
November 21, 2023
Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I-II follicular lymphoma from the SEER database (2000-2015)
Qiuzi Zhong, Ye Liu, Yunpeng Wu, et al.
BMC Cancer
|
January 17, 2020
Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A)
Mingqiu Chen, Xiaohong Liu, Chun Han, et al.
Oncotarget
|
April 30, 2016
Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
Jiang Chen, Tong Ji, Jie Zhao, et al.
BMC Cancer
|
January 8, 2025
Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03 A)
Yuanji Xu, Chuyan Lin, Chun Han, et al.
Scientific Reports
|
July 21, 2025
Accuracy and acceptability of self-sampling HPV testing in cervical cancer screening: a population-based study in rural Yunnan, China
Rufei Duan, Hongying Yang, Xiuwei Zhai, et al.
Elife
|
October 21, 2024
Proteogenomic analysis of air-pollution-associated lung cancer reveals prevention and therapeutic opportunities
Honglei Zhang, Chao Liu, Shuting Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
February 18, 2025
[Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022]
Ruke Tang, Yujie Lei, Lianhua Ye, et al.
The Lancet. Oncology
|
January 15, 2026
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
Liang Zhang, Xiqin Zhang, Lin Wu, et al.
Nature Communications
|
May 25, 2026
Directing intermediate phase crystallographic orientation promotes carbon-based CsPbI<sub>3</sub> perovskite solar cells to beyond 20% efficiency
Gaofeng Li, Jieke Tan, Changqing Lin, et al.
JTO Clinical and Research Reports
|
February 19, 2024
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis
Jie Wang, Yi-Long Wu, Shun Lu, et al.
Page
of 17